| abstract |
The present invention provides methods of treating, preventing, inhibiting, delaying the onset, or alleviation of a neurological disorder of the immune system that may include administering an effective amount of a compound comprising an antibody or an antigen-binding fragment of an antibody of a subject in need of treatment, preventing, inhibiting, delaying the onset, or alleviation of a neurological disorder of the immune system . The antibody or antigen-binding fragment of an antibody specifically binds to CD49a. |